Edition:
United Kingdom

Gene Techno Science commences phase III clinical trial for biosimilars in ophthalmology


Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Gene Techno Science Co Ltd <4584.T>:Says it commenced the phase III clinical trial for biosimilars in ophthalmology, which is a joint work between the co and Senju Pharmaceutical Co Ltd . 

Latest Developments forNoritsu Koki Co Ltd

Company Quote

1953.0
-37.0 -1.86%
7:00am BST